These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28284526)

  • 1. Association between glucose intolerance and bacterial colonisation in an adult population with cystic fibrosis, emergence of Stenotrophomonas maltophilia.
    Lehoux Dubois C; Boudreau V; Tremblay F; Lavoie A; Berthiaume Y; Rabasa-Lhoret R; Coriati A
    J Cyst Fibros; 2017 May; 16(3):418-424. PubMed ID: 28284526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease.
    Waters V; Yau Y; Prasad S; Lu A; Atenafu E; Crandall I; Tom S; Tullis E; Ratjen F
    Am J Respir Crit Care Med; 2011 Mar; 183(5):635-40. PubMed ID: 20889901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystic fibrosis related diabetes is not independently associated with increased Stenotrophomonas maltophilia infection: Longitudinal data from the UK CF Registry.
    Frost F; Nazareth D; Shaw M; Walshaw MJ
    J Cyst Fibros; 2019 Mar; 18(2):294-298. PubMed ID: 30741162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for emergence of Stenotrophomonas maltophilia in cystic fibrosis.
    Talmaciu I; Varlotta L; Mortensen J; Schidlow DV
    Pediatr Pulmonol; 2000 Jul; 30(1):10-5. PubMed ID: 10862157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal study of Stenotrophomonas maltophilia antibody levels and outcomes in cystic fibrosis patients.
    Wettlaufer J; Klingel M; Yau Y; Stanojevic S; Tullis E; Ratjen F; Waters V
    J Cyst Fibros; 2017 Jan; 16(1):58-63. PubMed ID: 27346471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of Stenotrophomonas maltophilia epidemiology in a French cystic fibrosis center.
    Capaldo C; Beauruelle C; Saliou P; Rault G; Ramel S; Héry-Arnaud G
    Respir Med Res; 2020 Nov; 78():100757. PubMed ID: 32759054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stenotrophomonas maltophilia: A marker of lung disease severity.
    Berdah L; Taytard J; Leyronnas S; Clement A; Boelle PY; Corvol H
    Pediatr Pulmonol; 2018 Apr; 53(4):426-430. PubMed ID: 29314745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis.
    Krzewinski JW; Nguyen CD; Foster JM; Burns JL
    J Clin Microbiol; 2001 Oct; 39(10):3597-602. PubMed ID: 11574579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stenotrophomonas maltophilia: to be or not to be a cystic fibrosis pathogen.
    Hansen CR
    Curr Opin Pulm Med; 2012 Nov; 18(6):628-31. PubMed ID: 22990659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic Stenotrophomonas maltophilia infection and exacerbation outcomes in cystic fibrosis.
    Waters V; Atenafu EG; Salazar JG; Lu A; Yau Y; Matukas L; Tullis E; Ratjen F
    J Cyst Fibros; 2012 Jan; 11(1):8-13. PubMed ID: 21849265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients.
    Waters V; Atenafu EG; Lu A; Yau Y; Tullis E; Ratjen F
    J Cyst Fibros; 2013 Sep; 12(5):482-6. PubMed ID: 23294530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic pulmonary infection with Stenotrophomonas maltophilia and lung function in patients with cystic fibrosis.
    Dalbøge CS; Hansen CR; Pressler T; Høiby N; Johansen HK
    J Cyst Fibros; 2011 Sep; 10(5):318-25. PubMed ID: 21463972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis.
    Amin R; Waters V
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD009249. PubMed ID: 27415821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis.
    Amin R; Waters V
    Cochrane Database Syst Rev; 2012 May; (5):CD009249. PubMed ID: 22592739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case-control study of Stenotrophomonas maltophilia acquisition in cystic fibrosis patients.
    Marchac V; Equi A; Le Bihan-Benjamin C; Hodson M; Bush A
    Eur Respir J; 2004 Jan; 23(1):98-102. PubMed ID: 14738239
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Willsey GG; Eckstrom K; LaBauve AE; Hinkel LA; Schutz K; Meagher RJ; LiPuma JJ; Wargo MJ
    J Bacteriol; 2019 Aug; 201(15):. PubMed ID: 31109991
    [No Abstract]   [Full Text] [Related]  

  • 17. Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosis.
    Goss CH; Otto K; Aitken ML; Rubenfeld GD
    Am J Respir Crit Care Med; 2002 Aug; 166(3):356-61. PubMed ID: 12153970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis.
    Amin R; Waters V
    Cochrane Database Syst Rev; 2014 Apr; (4):CD009249. PubMed ID: 24696136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pan-Resistant Achromobacter xylosoxidans and Stenotrophomonas maltophilia Infection in Cystic Fibrosis Does Not Reduce Survival After Lung Transplantation.
    Lobo LJ; Tulu Z; Aris RM; Noone PG
    Transplantation; 2015 Oct; 99(10):2196-202. PubMed ID: 25856407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis.
    Amin R; Jahnke N; Waters V
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009249. PubMed ID: 32189337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.